Article Menu

Export Article

More by Authors Links

Article Data

  • Views 1072
  • Dowloads 113

Original Research

Open Access

Uterine serous papillary carcinoma Clinical and immunopathological study of 9 cases

  • K. Sykiotis1
  • A. Kondi-Pafiti2
  • D. Giannaris1
  • J. Kouvaris3
  • A. Papayannopoulou2,*,
  • E. Salamalekis1

1Second Dept. of Obstetrics and Gynecology, Areteion Hospital, University of Athens, Greece

2Dept. of Pathology, Areteion Hospital, University of Athens, Greece

3Dept. of Radiology, Areteion Hospital, University of Athens, Greece

DOI: 10.12892/ejgo200106456 Vol.22,Issue 6,November 2001 pp.456-458

Published: 10 November 2001

*Corresponding Author(s): A. Papayannopoulou E-mail:

PDF (2.38 MB) View Full-text

Abstract

From January 1993 to December 1998, nine patients with serous papillary endometrial carcinoma (SPEC) were diagnosed and treated at the 2nd Department of Obstetrics and Gynecology, Areteion University Hospital. The incidence of SPEC in our Clinic was 6.77%. The mean age of patients was 65.5 years (range 54-82 years). All patients underwent total abdominal hysterectomy, bilateral salpingo-oophorectomy and epiploectomy. Abdominal and para-aortic lymph node sampling was performed in all cases and peritoneal washings were examined cytologically. Histological sections of the specimens, stained with haematoxylin-eosin, were retrieved from the Laboratory of Pathology and re-evaluated by two pathologists. All cases conformed to the diagnostic criteria for SPEC. Immunohistochemical studies were performed in paraffin blocks retrieved from the files, by a streptavidin-viotin method for the detection of vimentin (ENZO monoclonal ab), secretory component (DAKO polyclonal ab), CEA (DAKO monoclonal ab), EMA (DAKO monoclonal ab). The hormonal receptor status, assessed by appropriate positive and negative controls, was studied as well. The presence of mucin and glycogen was studied by histochemical reaction, PAS, PAS diastase and mucicarmine. Serous papillary carcinoma is an unusual but distinct type of endometrical adenocarcinoma, a non-hormonal dependent tumor, with aggressive biologic behavior. Its recognition is mandatory for a correct therapeutic approach.

Keywords

Uterus; Adenocarcinoma; Serous carcinoma; Papillary carcinoma; Immunohistochemistry

Cite and Share

K. Sykiotis,A. Kondi-Pafiti,D. Giannaris,J. Kouvaris,A. Papayannopoulou,E. Salamalekis. Uterine serous papillary carcinoma Clinical and immunopathological study of 9 cases. European Journal of Gynaecological Oncology. 2001. 22(6);456-458.

URL:

https://www.ejgo.net/articles/10.12892/ejgo200106456

References

[1] FIGO special report on gynecologic cancer. Int. 1. Gynec. Obstet. Special Issue (Guest eds.). Benedet J. L.,P ecorelliS ., 2000, 70(2), 231.

[2] Hendrickson M., Ross J.,E ifel P. et al.: "Uterine papillary serous carcinoma. A highly malignant form of endometrial adenocarcinoma". Amer. 1. Surg. Pathol., 1982, 6, 93.

[3] Christopherson W. M.,A lberhasky R.C .,C onnelly P. J.: "Carcinoma of the endometrium. II. Papillary adenocarcinoma: A clinical pathological study of 46 cases". Amer. J. Clin Pathol., 1982. 77, 534.

[4] Jeffirey J. F., Krepart G. V., Lotocki R. J.: "Endometrial serous adenocarcinoma of the endometrium". Ohstet. Gynecol., 1986, 67, 670.

[5] Sutton G.P ., Brill L.,M ichael H. et al.: "Malignant papillary lesions of the endometrium". Gynecol. Oncol., 1987, 27, 294.

[6] Walker A. N., Mills S. E.: "Serous papillary carcinoma of the endometrium. A clinicopathological study of 11 cases". Diag Gynecol. Obstet., 1982, 4, 261.

[7] Chen J. L., Trost D. C., Wilkinson E. J.: "Endometrial serous adenocarcinoma of the endometrium: Two clinicopathological types". Int. J. Gynecol. Pathol., 1985, 4, 279.

[8] Hendrickson M. R., Kempson R. L.: "Surgical pathology of the uterine corpus". ln: Bennington J. (ed.),M ajor Problems in Pathology, Vol. 12,P hiladelphia, W.B. Saunders, 1980. Vol. 12

[9] Lauchlan S. C.: "Pap仆lary carcinoma of the endometrium". Arch Pathol. Lab. Med., 1981, 105. 615.

[10] Cefis F.,C arinelli S. G.,M arzi M.M . et al.: "Endometrial adenocarcinoma with psammoma bodies". Tumori, 1979, 65, 359.

[11] LiVolsi V. A.: "Adenocarcinoma of the endometrium with psammoma bodies". Obstet. Gynecol.. 1977, 50, 725.

[12] Factor S. M.: "Papillary adenocarcinoma of the endometrium with psammoma bodies". Arch. Pathol., 1974, 98, 201.

[13] Hameed K., Morgan D. A.: "Papillary adenocarcinoma of the endometrium with psammoma bodies. Histology and fine structure". Cancer, 1972, 29, 1326.

[14] Weaver R. J.: "Endometrial carcinoma with psammoma bodies 111 the vaginal smear". Amer. 1. Ohstet. Gynecol., 196 7, 97, 869.

[15] Spjut H. J., Jaufman R.H., Carrig S.S.: "Psammoma bodies in cervico-vaginal smear". Acta Cytol., 1964, 8, 352.

[16] Liapis A., Paphiti A., Carvouni E. et al.: "Clinicopathological study of serous papillary carcinoma of the endometrium in three cases". Eur. J. Gynaecol. Oncol., 1997, 8, 78.

Submission Turnaround Time

Top